PubRank

Megan E Piper

Author PubWeight™ 66.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 2004 9.30
2 Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res 2007 5.54
3 A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 2008 3.25
4 New methods for tobacco dependence treatment research. Ann Behav Med 2011 2.44
5 The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med 2011 2.43
6 Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am J Psychiatry 2012 2.02
7 Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med 2009 1.95
8 Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob Res 2009 1.84
9 Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res 2010 1.63
10 Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 2010 1.61
11 Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers. Ann Behav Med 2012 1.52
12 Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J 2011 1.50
13 Smoker characteristics and smoking-cessation milestones. Am J Prev Med 2011 1.47
14 Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol 2011 1.33
15 Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking. Nicotine Tob Res 2005 1.27
16 The Wisconsin Predicting Patients' Relapse questionnaire. Nicotine Tob Res 2009 1.20
17 The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. J Consult Clin Psychol 2011 1.20
18 Smoking intensity and lipoprotein abnormalities in active smokers. J Clin Lipidol 2009 1.19
19 Time-varying processes involved in smoking lapse in a randomized trial of smoking cessation therapies. Nicotine Tob Res 2014 1.19
20 Depression predicts smoking early but not late in a quit attempt. Nicotine Tob Res 2007 1.17
21 Advancing the understanding of craving during smoking cessation attempts: a demonstration of the time-varying effect model. Nicotine Tob Res 2013 1.12
22 Effects of smoking intensity and cessation on inflammatory markers in a large cohort of active smokers. Am Heart J 2010 1.10
23 Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives: II. Evidence from a laboratory self-administration assay. J Abnorm Psychol 2010 1.06
24 Tobacco Dependence: Insights from Investigations of Self-Reported Smoking Motives. Curr Dir Psychol Sci 2010 1.02
25 Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence. J Abnorm Psychol 2012 1.00
26 WISDM primary and secondary dependence motives: associations with self-monitored motives for smoking in two college samples. Drug Alcohol Depend 2010 1.00
27 Relations of alcohol consumption with smoking cessation milestones and tobacco dependence. J Consult Clin Psychol 2012 0.98
28 Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones. Psychol Addict Behav 2012 0.98
29 A dynamical systems approach to understanding self-regulation in smoking cessation behavior change. Nicotine Tob Res 2013 0.97
30 Increasing consumer demand among Medicaid enrollees for tobacco dependence treatment: the Wisconsin "Medicaid covers it" campaign. Am J Health Promot 2011 0.96
31 Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res 2011 0.96
32 Obesity and smoking: comparing cessation treatment seekers with the general smoking population. Obesity (Silver Spring) 2009 0.95
33 Long-term effects of smoking and smoking cessation on exercise stress testing: three-year outcomes from a randomized clinical trial. Am Heart J 2011 0.95
34 Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide. Ann Am Thorac Soc 2014 0.94
35 Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures. Psychol Assess 2009 0.92
36 Risk factors for subclinical carotid atherosclerosis among current smokers. Prev Cardiol 2010 0.87
37 Early lapses in a cessation attempt: lapse contexts, cessation success, and predictors of early lapse. Nicotine Tob Res 2013 0.86
38 Effects of smoking and cessation on subclinical arterial disease: a substudy of a randomized controlled trial. PLoS One 2012 0.83
39 Battling tobacco use at home: an analysis of smoke-free home rules among U.S. veterans from 2001 to 2011. Am J Public Health 2014 0.82
40 New methods for advancing research on tobacco dependence using ecological momentary assessments. Nicotine Tob Res 2014 0.78
41 A comparison of the nicotine lozenge and nicotine gum: an effectiveness randomized controlled trial. WMJ 2008 0.77
42 Cognitive conflict following appetitive versus negative cues and smoking cessation failure. Psychopharmacology (Berl) 2011 0.77
43 Electrocardiographic changes associated with smoking and smoking cessation: outcomes from a randomized controlled trial. PLoS One 2013 0.75